EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plasma proteomics of cerebrovascular disease, cognitive decline, and clinical outcomes

Ming Ann Sim, Saima Hilal, Jasper Tromp, Eugene S J Tan, James Doecke, Oi Wah Liew, Vera Yuan Cai, Siew Pang Chan, Eddie Jun Yi Chong, Anqi Toh, Tan Boon Yeow, Narayanaswamy Venketasubramanian und 11 weitere

Alzheimer's & Dementia · 2026-08 · 22 (8)

DOI: 10.1002/alz.71728 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 19.08.2026. Verfasst von Ming Ann Sim und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Memory Aging and Cognition Centre, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Cerebrovascular Disorders, Proteomics, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Medical Research Council, National University Health System, National University of Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION The plasma proteomic signatures underlying cerebrovascular disease (CeVD) remains poorly understood. METHODS A total of N = 2534 participants across two independent longitudinal Southeast‐Asian cohorts were included. We profiled 1441 baseline plasma proteins in a memory‐clinic cohort ( N = 518), followed‐up for 4 years. Proteins associating with baseline and longitudinal CeVD lesions (i.e., white matter hyperintensity volume, lacunes, cerebral microbleeds, and cortical infarcts) were reported. The prognostic value of CeVD‐associated proteins was evaluated for incident major cardiovascular/cerebrovascular events (MACCE) and mortality. External validation of key proteins for mortality was performed in the plasma proteome of an independent cardiovascular cohort ( N = 2016). RESULTS We report distinct and overlapping plasma proteins for baseline and longitudinal CeVD, representing diverse biological processes. Four proteins were prioritized as mediators of CeVD‐associated cognitive decline, and predictors of MACCE. These proteins were validated for incident mortality across both cohorts: neurofilament light chain (NEFL), latent‐transforming growth factor beta‐binding protein 2 (LTBP2), cysteine‐rich motor neuron 1 protein (CRIM1), and urokinase plasminogen activator surface receptor (PLAUR). DISCUSSION The prognostic proteins prioritized in our study provide robust signals in two cohorts, representing potential mechanistic targets for CeVD and health outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebrovascular DisordersProteomicsCognitive DysfunctionHumansFemaleMaleLongitudinal StudiesAgedBiomarkersPrognosisCohort Studies

Stichwörter der Autor:innen

Southeast‐Asianblood biomarkercerebrovascular diseasecognitionheart‐brainmortalityproteomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Pharmacology, Memory Aging and Cognition Centre, National University of Singapore, Singapore, Singapore.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Department of Intensive Care Medicine, National University Health System, Singapore, Singapore.
  • Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
  • National University Heart Centre, Singapore, Singapore.
  • Australian E-Health Research Centre, CSIRO, Herston, QLD, Australia.

Förderung

  • National Medical Research Council
  • National University Health System
  • National University of Singapore

Zitieren

APA

Sim, M. A., Hilal, S., Tromp, J., Tan, E. S. J., Doecke, J., Liew, O. W., Cai, V. Y., Chan, S. P., Chong, E. J. Y., Toh, A., Yeow, T. B., Venketasubramanian, N., Barascuk-Michaelsen, N., Sim, D., Leong, G. K. T., Yeo, D. P. S., Ong, H. Y., Ling, L. H., Lam, C., …, & Chen, C. L. H. (2026). Plasma proteomics of cerebrovascular disease, cognitive decline, and clinical outcomes. Alzheimer's & Dementia, 22(8). https://doi.org/10.1002/alz.71728

Vancouver

Sim MA, Hilal S, Tromp J, Tan ESJ, Doecke J, Liew OW, et al. Plasma proteomics of cerebrovascular disease, cognitive decline, and clinical outcomes. Alzheimer's & Dementia. 2026;22(8). doi:10.1002/alz.71728

BibTeX
@article{Sim2026,
  author = {Sim, Ming Ann and Hilal, Saima and Tromp, Jasper and Tan, Eugene S J and Doecke, James and Liew, Oi Wah and Cai, Vera Yuan and Chan, Siew Pang and Chong, Eddie Jun Yi and Toh, Anqi and Yeow, Tan Boon and Venketasubramanian, Narayanaswamy and Barascuk-Michaelsen, Natasha and Sim, David and Leong, Gerard Kui Toh and Yeo, Daniel Poh Shuan and Ong, Hean Yee and Ling, Lieng Hsi and Lam, Carolyn and Lai, Mitchell K P and Choi, Hyungwon and Richards, Arthur Mark and Chen, Christopher L H},
  title = {Plasma proteomics of cerebrovascular disease, cognitive decline, and clinical outcomes},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {8},
  doi = {10.1002/alz.71728}
}
Kostenlos starten →